Clinical Trials Logo

Clinical Trial Summary

The purpose of this multi-center study is to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established (appendicular skeletal) non union fractures, when used with one of the commonly employed commercially available allograft chip matrices.


Clinical Trial Description

The current standard of care for regeneration of atrophic long bone fracture non-union is autologous bone and marrow chiseled from the patient's iliac crest in open surgery under general anesthesia. This method for harvesting bone and marrow is associated with substantial morbidity of long-term pain, the possibility of deep-seated infection at the site of the bone harvest and other indirect consequences such as extended time of surgery, substantial expense and the potential for blood transfusion. The procedure is also associated with a bone graft failure rate of at least 20%. Due to the substantial morbidity resulting from the aggressive open surgical procedure, alternatives are sought. Current alternatives to autologous bone include commercially available synthetic, xenograft and allograft matrices, either used alone or combined with bone autograft. Cell-free substitutes, such as matrices combined with platelet rich plasma or recombinant bone morphogenic proteins for osteoinductivity, are also used. These alternatives, although less morbid than a full bone harvest, have not yet been stringently determined to be equivalent. Therefore, there is a continuing search for additional improved alternatives. Aastrom Biosciences, Inc. has developed a unique process for growing human bone marrow, including the early stem cell populations, from small samples of percutaneously aspirated bone marrow. The process is carried out in the AastromReplicell Cell Production System (ARS). The study will be performed to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established non union fractures, when used with one of the commonly employed commercially available allograft chip matrices. The bone marrow cells will be obtained by a brief, percutaneous, small volume aspiration (approximately 30 - 50 ml) from the posterior iliac crest obtained under local and conscious sedation. Percutaneous marrow aspiration is substantially less morbid and time consuming than the current open surgical process of bone autograft harvest. The study will treat up to 36 patients (11 in the first group and 25 in a second group). Patients will be treated using standard surgical procedures for the treatment of non union fractures (including commonly used hardware needed to stabilize the fracture). The processed cells will be mixed with commercially available bone matrix during surgery and placed in the area of the fracture. Patients will be monitored for 12 months following the surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00424567
Study type Interventional
Source Vericel Corporation
Contact
Status Terminated
Phase Phase 1/Phase 2
Start date October 2003
Completion date June 2007

See also
  Status Clinical Trial Phase
Recruiting NCT03970941 - Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Completed NCT00916981 - Treatment of Atrophic Nonunion by Preosteoblast Cells Phase 1/Phase 2
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Not yet recruiting NCT01756144 - rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport N/A
Enrolling by invitation NCT06103396 - Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) Phase 1/Phase 2
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System